Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate
about
Treatment With Lisdexamfetamine Dimesylate Improves Self- and Informant-Rated Executive Function Behaviors and Clinician- and Informant-Rated ADHD Symptoms in Adults: Data From a Randomized, Double-Blind, Placebo-Controlled Study.Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancersPiloting a new approach to the treatment of obesity using dexamphetamine.Development of the Global Disability Scale (Glo.Di.S): preliminary resultsLong-term (1 year) safety and efficacy of methylphenidate modified-release long-acting formulation (MPH-LA) in adults with attention-deficit hyperactivity disorder: a 26-week, flexible-dose, open-label extension to a 40-week, double-blind, randomisePsychotherapy in adult attention deficit hyperactivity disorder: implications for treatment and research.A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder.Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity.Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder.Participant-perceived quality of life in a long-term, open-label trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate.Changes in Behaviour Symptoms of Patients with Attention Deficit/Hyperactivity Disorder during Treatment: Observation from Different Informants.Efficacy of Cognitive Behavioral Therapy With and Without Medication for Adults With ADHD.
P2860
Q30742299-8DE6E93F-A981-4D01-9578-C9F6DA09EECFQ34349991-D0D47382-116B-420F-A5DB-20D686C21FDFQ35063613-FC7E400B-C577-4D13-A3E7-D7EABD0CD085Q36209425-DAF4262A-7502-4167-9EFE-693556793F3FQ36364178-9DDB3D89-514A-48CA-BA48-8C39456ED83DQ38053445-B9795478-6BFB-49F4-BE66-259A85345021Q38239633-20A755C1-C189-46D5-9FC5-E26A5A9A59EAQ38663434-A3569139-53B1-4216-B9D2-6B47EB6EA76CQ38827483-6081F82B-9AC1-40C2-8767-095C00631682Q39749601-6F3FAAE6-2B7C-4474-8ED3-78079C5A3D03Q41436769-144BC431-C0C0-499B-953F-982F6A6F0AAAQ41513750-12440CDA-2FE4-4656-9778-E41AE27A0FBCQ53626856-950E029B-A1FF-498D-9B7E-0969DA4CC62B
P2860
Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Functional improvement and cor ...... ng long-acting methylphenidate
@ast
Functional improvement and cor ...... ng long-acting methylphenidate
@en
type
label
Functional improvement and cor ...... ng long-acting methylphenidate
@ast
Functional improvement and cor ...... ng long-acting methylphenidate
@en
prefLabel
Functional improvement and cor ...... ng long-acting methylphenidate
@ast
Functional improvement and cor ...... ng long-acting methylphenidate
@en
P2093
P2860
P1476
Functional improvement and cor ...... ng long-acting methylphenidate
@en
P2093
A Philipsen
B Schäuble
J A Ramos-Quiroga
J C van Oene
J Dejonckheere
J J S Kooij
J K Buitelaar
P2860
P304
P356
10.1017/S0033291711000845
P407
P577
2011-06-01T00:00:00Z